Economic and Resource Utilization Analysis of Outpatient Management of Fever and Neutropenia in Low-Risk Pediatric Patients With Cancer
- 1 May 1999
- journal article
- clinical trial
- Published by Wolters Kluwer Health in Journal of Pediatric Hematology/Oncology
- Vol. 21 (3) , 212-218
- https://doi.org/10.1097/00043426-199905000-00009
Abstract
To measure resource allocation in outpatient management of fever and neutropenia in low-risk pediatric patients with cancer and its impact on their families. A prospective clinical trial was conducted. Eligible patients received a single dose of intravenous (IV) antibiotics and were observed for several hours in clinic. Patients were randomly assigned to continue either IV or oral antibiotics and were seen daily as outpatients. Charges were calculated based on the number of resources used and Medicare/Medicaid reimbursement schedules. A questionnaire was used to measure the impact of outpatient treatment on the family. Seventy-three episodes of fever and neutropenia were studied. The median duration of treatment was 4 days. Eighty-six percent of the episodes were managed without hospitalization. The median calculated charge was $1840. The median calculated charge for patients receiving oral antibiotics was $1544 and was significantly less than the $2039 median charge for outpatients treated with IV antibiotics. The estimated charge for comparable inpatient treatment was $4503. Nearly all families preferred outpatient care, and few reported a loss of work hours or increased child care expenses. Outpatient treatment of low-risk episodes of fever and neutropenia is substantially less costly than inpatient care and is preferred by most families.Keywords
This publication has 17 references indexed in Scilit:
- 1997 Guidelines for the Use of Antimicrobial Agents in Neutropenic Patients with Unexplained FeverClinical Infectious Diseases, 1997
- Human Granulocyte Colony-Stimulating Factor after Induction Chemotherapy in Children with Acute Lymphoblastic LeukemiaNew England Journal of Medicine, 1997
- Granulocyte colony-stimulating factor in established febrile neutropenia: a randomized study of pediatric patients.Journal of Clinical Oncology, 1997
- EARLY EMPIRIC ANTIBIOTIC THERAPY FOR FEBRILE NEUTROPENIA PATIENTS AT LOW RISKInfectious Disease Clinics of North America, 1996
- Predicting the risk of bacteremia in childen with fever and neutropenia.Journal of Clinical Oncology, 1996
- The identification of febrile, neutropenic children with neoplastic disease at low risk for bacteremia and complications of sepsisCancer, 1996
- Health care outcomes case study: Febrile neutropeniaAmerican Journal of Health-System Pharmacy, 1995
- Safety and cost effectiveness of early hospital discharge of lower risk children with cancer admitted for fever and neutropeniaCancer, 1994
- Management of Fever in Patients with Cancer and Treatment-Induced NeutropeniaNew England Journal of Medicine, 1993
- Risk assessment in cancer patients with fever and neutropenia: a prospective, two-center validation of a prediction rule.Journal of Clinical Oncology, 1992